Schizophrenia & Other Psychotic Disorders
Latest News
New guidance to optimize antipsychotic treatment
Patients receiving polypharmacy can benefit from TDM because some coprescribed medications can raise or lower antipsychotic blood levels.
From the Journals
Aripiprazole lauroxil rivals paliperidone palmitate in schizophrenia
The baseline PANSS score was 94.1 for the aripiprazole patients and 94.6 for those who received paliperidone.
From the Journals
Movement-based yoga ‘viable’ for depression in many mental disorders
Individuals who performed yoga showed a greater reduction in depressive symptoms, compared with the three control groups.
Evidence-Based Reviews
Cannabidiol for psychosis: A review of 4 studies
Some early research suggests CBD might be beneficial for patients with psychosis, but evidence is mixed.
Commentary
Planning for a psychiatric COVID-19–positive unit
Frequent and open communication with all professional stakeholders is important in the planning process, three experts said.
From the Journals
New ‘atlas’ maps links between mental disorders, physical illnesses
“We found that women with anxiety disorders have a 50% increased risk of developing a heart condition or stroke,” said Dr. John McGrath.
Evidence-Based Reviews
Time to retire haloperidol?
For emergency agitation, evidence suggests newer alternatives may be a better choice.
Conference Coverage
Anti-NMDAR encephalitis or primary psychiatric disorder?
Once anti-NMDA receptor encephalitis is identified, most patients will benefit from immunotherapy and tumor removal, though recovery may take...
Commentary
Drive-up pharmacotherapy during the COVID-19 pandemic
This solution allows patients to safely receive medications that must be administered in person.
From the Journals
First-in-class schizophrenia drug safe, effective, durable
SEP-363856 also led to significant improvement in several secondary outcomes, including overall illness severity.
Pearls
Is psychosis toxic to the brain?
Because untreated psychosis can result in irreversible structural brain damage, clinicians must act swiftly to provide assertive treatment.